We're here for you, with one-on-one support and resources.

IMBRUVICA® By Your Side* gives you one-on-one support to help you start and stay on track with your prescribed treatment plan. We help all eligible IMBRUVICA® patients and caregivers, regardless of your insurance coverage or language preference. Once you enroll, we'll give you:

Financial guidance to help you understand your insurance and find potential savings on IMBRUVICA® 

Financial Support

A personal Ambassador who will answer your IMBRUVICA® questions and give you educational support

Ambassador Program

Helpful resources about your disease and how to take IMBRUVICA®​​​

Additional Resources

It's easy to enroll in IMBRUVICA® By Your Side.

You can also call 1-888-YourSide (1-888-968-7743) to enroll or ask us questions about By Your Side.

If you have Medicare, Medicaid, other government insurance, or are uninsured, your Ambassador can connect you with an Insurance Specialist, who can explain costs and coverage in more detail and find potential savings for you.


copay card

IMBRUVICA® By Your Side Copay Card

If you have commercial insurance, you may pay as little as $0 per prescription.‡ Enroll now for more information about our Copay Card.​​​​​​

Already have an IMBRUVICA® By Your Side Copay Card? 
Click here to access your Copay Card.

Enroll Now

IMBRUVICA® By Your Side patient support program is not intended to provide medical advice, replace prescribed treatment plans, or provide treatment or case management services. Patients are advised to talk to their healthcare provider and treatment team about any medical decisions and concerns they may have.

By Your Side Ambassadors are provided by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie Company, and do not work under the direction of your healthcare professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.

Eligible patients may pay as little as $0 per prescription of IMBRUVICA®. Rules and maximum limits apply. Patients currently using the IMBRUVICA® Copay Card are not eligible for retroactive billing or reimbursement of previous copays. The IMBRUVICA® Copay Card is available to patients with commercial prescription coverage for IMBRUVICA® who meet eligibility criteria. The IMBRUVICA® Copay Card cannot be used by patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs, including Medicare Part D, Medicare Advantage Plan, Medicaid, Medigap, VA, DOD, and TRICARE, or where prohibited by law or the patient’s health insurance provider. The IMBRUVICA® Copay program may be updated or discontinued at any time without notice.

Pharmacyclics, an AbbVie Company, may collect your personal data through your online and offline interactions with us, including your contact, demographic, geolocation, and health-related data. We may also collect your online usage data automatically through cookies and similar technologies. We use this data for several purposes, such as to provide you with and improve our programs, services, and products, customize your experiences, and for research and analytics. We retain your personal data for as long as necessary to fulfill these purposes or to comply with our record retention obligations. We do not sell your personal data but may use and disclose your personal data with marketing and advertising partners to deliver you ads based on your interests inferred from your activity across other unaffiliated sites and services (“online targeted advertising”) and for website analytics. To opt out of the use or disclosure of your personal data for online targeted advertising or for website analytics, go to Your Privacy Choices on our website. For more information on the personal data categories we collect, the purposes for their collection, our disclosures to third parties, your data subject rights, and our data retention criteria, visit our Privacy Notice.

Through my submission of the program enrollment form, I consent to the collection, use, and disclosure of my personal health data, as described in the Privacy Notice above and in AbbVie’s Privacy Notice in the How We May Disclose Personal Data section. My consent is required to process sensitive personal data under certain privacy laws, and I have the right to withdraw my consent by visiting Your Privacy Choices on AbbVie’s website.

IMBRUVICA® (ibrutinib) is covered by U.S. Patents, which are listed in FDA's Orange Book (available at